Connect with us

Health

20% of African Nations Lack Access to Cancer Treatments

Published

on

By Dipo Olowookere

On Sunday, February 4, 2018, the World Cancer Day was marked to create awareness for the disease, which is fast killing many across the world.

A non-profit company and a subsidiary of Merck KGaA Germany, Merck Foundation, marked the ‘World Cancer Day 2018’ to create awareness around cancer and build cancer care capacity with the aim to increase the limited number of oncologists across Africa and developing countries.

In June 2017, BIO Ventures for Global Health (BVGH), and the African Organization for Research and Training in Cancer (AORTIC), released a white paper on the African continent’s emerging cancer crisis.

It was disclosed that over 20 percent of African countries have no access to cancer treatments at all, while access is limited and sporadic in other countries.

Later-stage diagnosis in African patients contributes to poorer outcomes. For example, 5-year female breast cancer relative survival rates are 46 percent in Uganda and 12% in The Gambia, compared with around 90 percent in developed countries.

CEO of Merck Foundation Dr Rasha Kelej, recently visited Muhimbili University of Health and Allied Science, Tanzania to meet the alumni of ‘Merck Oncology Fellowship Program’ with the aim to evaluate the impact of the one and two-year medical oncology fellowship programs conducted in Tata memorial center in India.

Through ‘Merck Oncology Fellowship Program’ foundation has trained the first medical oncologist in Tanzania, Dr. Christina V. Malichewe.

During her visit to Tanzania Dr. Rasha Kelej emphasized, “We strongly believe that building professional capacity is the right strategy to improve access to quality and equitable cancer care in the continent. Dr. Christina is one of the 59 future oncologists, Merck Foundation has committed to train for Africa.”

The first medical oncologist in Tanzania, Dr. Christina V. Malichewe said, “I can now make difference for my patients. We don’t have medical oncology to manage patients through chemotherapy, we only have clinical oncologists and radiotherapists. Thus, one-year medical oncology fellowship in India has enabled me to save many lives, every day. Thanks to Merck Foundation for this opportunity in Tanzania.”

During her meeting with Dr. Christina, Dr. Rasha Kelej said “I’ve enjoyed every moment with her, witnessing the great impact she makes every day on her patients’ lives. Through her, we transform people’s lives every day.”

Sarah Opendi, Uganda Minister of State of Health said, “Merck Foundation and ministry of health of Uganda have been partners for a very long time, we have been working together on various issues with special focus on cancer and infertility. We appreciate the efforts of Merck Foundation in building cancer care capacity in Uganda and other African countries, and we hope soon we would have world class cancer facilities and expert locally in our beloved country.”

The first fellow for ‘Merck Oncology Fellowship Program’ from Uganda Dr. Sekitene Seei Buwambaza said, “Merck Oncology Fellowship program is very important to me because it is giving me an opportunity to learn and improve on the way, I have been doing things concerning the management of cancer patients. It is also ushering me into the new trend that cancer care and research is taking in this 21st century. A bond with Merck Foundation as an alumnus is going to keep me updated with new developments in cancer care.”

Fellowship Program’ from Uganda, Dr. Musana Othiniel, an obstetrician and gynaecologist from Uganda, “Uganda as a country lacks a national cancer screening program yet cervical cancer and breast cancer remains the most common cancers and accounts for the highest proportion of cancers requiring treatment. The country also has a shortage of good gynae-oncology clinicians, researchers and educators in Uganda hence limiting access for women with cancer to screening, diagnostic and treatment services.”

He further added, “The ‘Merck Oncology Fellowship Program’ will expand my knowledge on the selection of appropriate clinical and research methodology used in gynae-oncology. I hope to improve my skills in carrying out appropriate and evidence-based clinical diagnosis and treatment but also empower me with excellent clinical education skill to mentor other young health workers in gynae-oncology.”

While Appreciating the efforts of Merck Foundation, Dr. Damas Dukundane, Merck Foundation oncology fellow from Rwanda said “When the right people are in charge then the right things happen. I am so excited to be part of this journey of change makers, where the history will remember us as the Merck Foundation fellows, who improved the lives of people with cancer in Africa, in the 21st century.”

Moreover, 50 future oncologists either joined or will join one, two or three years ‘Merck Oncology Fellowship Program’ from many sub-Saharan African countries out of which, countries such as Gambia and Liberia never had oncologists.

Merck Foundation will provide eight doctors from both Uganda and Tanzania with one -year medical oncology fellowship program. Furthermore, together with university of Nairobi, Merck Foundation established the first two-year medical oncology fellowship program for Sub-Saharan Africa.

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Lagos Commences Screening of Newborns for Sickle Cell Disease

Published

on

sickle cell disease screening Lagos

By Modupe Gbadeyanka

The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.

It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.

The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.

She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.

The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.

It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.

Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.

She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.

Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.

He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.

One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.

Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.

“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.

Continue Reading

Health

Evon Labs Unveils Health-Tech Incubation Initiative HealthX Catalyst

Published

on

Evon Labs Isioma Udeozo HealthX Catalyst

By Aduragbemi Omiyale

A 12-week health-tech incubation programme tailored for early-stage founders in Nigeria has been introduced by an innovation and venture-building platform, Evon Labs.

This initiative, known as HealthX Catalyst, will help participants to create scalable, investable solutions for Africa’s urgent healthcare issues.

The programme is underway, with 12 selected founders nearing the final weeks of intensive incubation, ending with a Demo Day on June 24, 2026, at the UNDP innovation centre in Lagos, where the small business owners will present their solutions to an audience of investors, healthcare leaders, development organisations, and technology partners.

The initiative selects early-stage healthcare founders and immerses them in a structured 12-week development process. Throughout this period, participants receive personalised and group mentorship from seasoned professionals across the healthcare, technology, and business sectors.

They also receive structured support for startup development, including refining business models, developing value propositions, and validating markets.

Additionally, participants gain access to a network of healthcare practitioners, sector experts, and industry leaders, along with targeted investment-readiness assistance to prepare them to engage with investors and strategic partners after the programme.

The result is a cohort of founders who move through the programme not simply with a refined pitch, but with a validated business model, a stronger professional network, and a clear pathway to growth.

To accelerate the most promising solutions beyond the programme, monetary grants will be awarded to the top three founders to support product development, pilot implementation, market validation, and early-stage scaling.

It was learned that HealthX Catalyst was developed in response to a structural gap in the African health-tech ecosystem.

Across the continent, a growing number of entrepreneurs are building solutions to healthcare problems from access and diagnostics to service delivery and health data infrastructure. Yet many of these early-stage ideas fail to progress beyond concept, not for lack of vision, but for lack of structured support: mentorship, startup development frameworks, industry access, and early-stage funding pathways. HealthX Catalyst was built to provide exactly that.

“Africa does not have a shortage of healthcare innovators. What it has lacked is the infrastructure to turn its ideas into sustainable businesses. HealthX Catalyst is that infrastructure, a serious, structured programme designed to take founders from early-stage ideas to investable startups.

“What we are seeing from this first cohort is exactly what we set out to create: founders who are not just building products, but building businesses that can scale and create lasting impact,” the founder of Evon Labs, Ms Isioma Udeozo, said of the unveiling of HealthX Catalyst.

The partners of the programme are the United Nations Development Programme (UNDP), Odua Investment Company Limited (OICL), Washington University of St Louis, Missouri, Lagos State Employment Trust Fund (LSETF), and Brooks Insights.

Continue Reading

Health

Binance Promises $250,000 for Ebola in DR Congo, Uganda

Published

on

Binance

By Aduragbemi Omiyale

The sum of $250,000 in humanitarian funding is to be provided by Binance to support the frontline response to the ongoing Ebola disease outbreak in the Democratic Republic of Congo (DRC) and Uganda.

The cryptocurrency exchange said the funds would be used to enable rapid response in high-risk and underserved areas, where access to healthcare infrastructure, protective resources, and timely public health information remains limited.

The money will be shared equally between the Uganda Red Cross Society and Doctors Without Borders / Médecins Sans Frontières (MSF), supporting urgent interventions in affected and high-risk communities.

Binance’s contribution will help strengthen emergency medical care and treatment, community awareness and prevention campaigns, contact tracing and containment support, and the provision of sanitation supplies and protective equipment for frontline workers.

By supporting both immediate response activities and preventative education, Binance aims to contribute to reducing transmission and strengthening community resilience.

“Communities across Africa continue to show extraordinary resilience in the face of complex challenges, but frontline responders should not have to face crises like this alone,” the co-chief executive of Binance, Mr Richard Teng, said.

“The teams working to contain the Ebola disease outbreak are delivering vital, life-saving support under incredibly difficult conditions.

“We are proud to support both the Uganda Red Cross Society and Doctors Without Borders as they work to protect vulnerable populations, strengthen local response efforts, and deliver urgent care where it is needed most,” he added.

Also commenting, the Secretary General for the Uganda Red Cross Society, Mr Robert Kwesiga, said, “Strong partnerships are essential during public health emergencies since we are not able to manage the outbreak alone.

“The support from Binance comes in so timely and handy, and will help us respond more rapidly, reach more at-risk communities, and reinforce the frontline services needed to help contain the outbreak and save lives.”

The MSF Emergency Programme Manager, Trish Newport, while speaking on the initiative, said, “The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning. In Ituri, many people already struggle to access healthcare and live with ongoing insecurity, making rapid action critical to prevent the outbreak from escalating further.”

Caused by the Bundibugyo virus, for which there is no approved vaccine or treatment, this Ebola disease outbreak has placed acute pressure on already fragile health systems in eastern DRC and the wider region.

Local authorities, international agencies, and humanitarian organisations are racing to contain it and protect affected communities.

Binance’s support is intended to reinforce these efforts at a critical moment. It reflects the company’s broader commitment to supporting communities across Africa through programmes focused on education, financial inclusion, digital skills development, and community empowerment.

In this case, Binance is extending that commitment to urgent humanitarian and public health needs by working alongside trusted organisations with deep frontline expertise.

Continue Reading

Trending